Lung Cancer

The following activities are available for studies related to the biology, screening, diagnosis, prevention, and treatment of small cell and non-small cell lung cancer.

• The Potential Role of mTOR Inhibitors in Non-Small Cell Lung Cancer
• Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial-An Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)
• Indications and Developments of Video-Assisted Thoracic Surgery in the Treatment of Lung Cancer
• Recent Advances with Topotecan in the Treatment of Lung Cancer
• The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments
• Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?
• Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development
• Multidisciplinary Treatment of Malignant Pleural Mesothelioma
• Sequential, Alternating, and Maintenance/Consolidation Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of the Literature
• Optimal Adjuvant Therapy for Non-Small Cell Lung Cancer — How to Handle Stage I Disease
• Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
• Genetic Polymorphisms of the Epidermal Growth Factor and Related Receptor in Non-Small Cell Lung Cancer—A Review of the Literature
• Understanding the New Genetics of Responsiveness to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
• Sorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer
• Response to Treatment and Survival of Patients with Non-Small Cell Lung Cancer Undergoing Somatic EGFR Mutation Testing
• Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer
• Lung Cancer Screening EXPIRED
• Clinical Implications of EGFR Expression in the Development and Progression of Solid Tumors: Focus on Non-Small Cell Lung Cancer EXPIRED
• How Do U.S. Medical Oncologists Learn and Apply New Clinical Trials Information from Press Releases in Nonmedical Media? A Case Study Based on ECOG 4599 EXPIRED
• Lung Cancer Highlights from ASCO 2005 EXPIRED
• Optimizing First-Line Treatment Options for Patients with Advanced NSCLC EXPIRED
• How Today's Developments in the Treatment of Non-Small Cell Lung Cancer Will Change Tomorrow's Standards of Care EXPIRED
• Three Emerging New Drugs for NSCLC-Pemetrexed, Bortezomib, and Cetuximab EXPIRED
• Emerging Role of Rexinoids in Non-Small Cell Lung Cancer: Focus on Bexarotene EXPIRED
• Quality-of-Life Considerations in Patients with Advanced Lung Cancer: Effect of Topotecan on Symptom Palliation and Quality of Life EXPIRED
• Update on the Role of Topotecan in the Treatment of Non-Small Cell Lung Cancer EXPIRED
• Topotecan in the First-Line Treatment of Small Cell Lung Cancer EXPIRED
• Emerging Role of Weekly Topotecan in Recurrent Small Cell Lung Cancer EXPIRED
• Topotecan in the Treatment of Recurrent Small Cell Lung Cancer: An Update EXPIRED
• Superior Sulcus Tumors: A Mini-Review EXPIRED
• Non-Small Cell Lung Cancer in the Elderly EXPIRED
• Topotecan in the Treatment of Relapsed Small Cell Lung Cancer Patients with Poor Performance Status EXPIRED
• HER1/EGFR Targeting: Refining the Strategy EXPIRED
• Docetaxel-Based Combined Modality Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer EXPIRED
• Chemotherapy Options for the Elderly Patient with Advanced Non-Small Cell Lung Cancer EXPIRED
• Use of Temozolomide with Other Cytotoxic Chemotherapy in the Treatment of Patients with Recurrent Brain Metastases from Lung Cancer EXPIRED
• Small Cell Lung Cancer: Current Therapy and Promising New Regimens EXPIRED
• Prophylactic Cranial Irradiation in Small-Cell Lung Cancer EXPIRED
• Lung Cancer Highlights EXPIRED
• Lung Cancer EXPIRED
• Is There a Preferred Combination Chemotherapy Regimen for Metastastic Non-Small Cell Lung Cancer? EXPIRED